Skip to main content

Table 2 Univariate analysis

From: Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus

 

OR

95% CI

p

ASA

0.75

0.70–0.81

<0.0001

ACEIs/ARBs

2.13

1.99–2.28

<0.0001

β-blockers

0.87

0.80–0.94

<0.0001

Statins

1.01

0.93–1.09

0.8054

Clopidogrel

0.81

0.76–0.87

<0.0001

  1. Odds ratio (OR) for claiming secondary prevention pharmacotherapy after first myocardial infarction during 2003–2006 in patients with vs. without diabetes mellitus. ASA: acetyl salicylic acid, ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, CI: confidence interval.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us